153 related articles for article (PubMed ID: 9798684)
21. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
22. A murine model for B-cell lymphomagenesis in immunocompromised hosts: c-myc-rearranged B-cell lines with a premalignant phenotype.
Felsher DW; Denis KA; Weiss D; Ando DT; Braun J
Cancer Res; 1990 Nov; 50(21):7042-9. PubMed ID: 2208171
[TBL] [Abstract][Full Text] [Related]
23. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages.
Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L
J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128
[TBL] [Abstract][Full Text] [Related]
24. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC.
Smith DP; Bath ML; Harris AW; Cory S
Oncogene; 2005 May; 24(22):3544-53. PubMed ID: 15688022
[TBL] [Abstract][Full Text] [Related]
25. Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice.
Lam QL; Lo CK; Zheng BJ; Ko KH; Osmond DG; Wu GE; Rottapel R; Lu L
Int Immunol; 2007 Mar; 19(3):267-76. PubMed ID: 17229817
[TBL] [Abstract][Full Text] [Related]
26. Raf-induced transformation requires an interleukin 1 autocrine loop.
Vale T; Ngo TT; White MA; Lipsky PE
Cancer Res; 2001 Jan; 61(2):602-7. PubMed ID: 11212256
[TBL] [Abstract][Full Text] [Related]
27. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus.
Wiener F; Coleman A; Mock BA; Potter M
Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005
[TBL] [Abstract][Full Text] [Related]
28. Reduced Myc overexpression and normal B-cell differentiation mediate resistance to avian leukosis virus lymphomagenesis.
Parghi SS; Brandvold KA; Bowers SJ; Neiman PE; Ruddell A
Oncogene; 2004 May; 23(25):4413-21. PubMed ID: 15064748
[TBL] [Abstract][Full Text] [Related]
29. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
Dolnikov A; Millington M; Sun LQ; Symonds G
Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
[TBL] [Abstract][Full Text] [Related]
30. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
[TBL] [Abstract][Full Text] [Related]
31. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
[TBL] [Abstract][Full Text] [Related]
32. Loss of myb expression in an aggressive SJL/J B-cell lymphoma.
Sopchak L; Thrush GR; Lerman SP; King SR
Oncogene; 1991 Aug; 6(8):1335-8. PubMed ID: 1886709
[TBL] [Abstract][Full Text] [Related]
33. Erythroproliferation in vitro can be induced by abl, fes, src, ras, bas, raf, raf/myc, erb B and cbl oncogenes but not by myc, myb and fos.
Klinken SP
Oncogene Res; 1988 Sep; 3(2):187-92. PubMed ID: 3226726
[TBL] [Abstract][Full Text] [Related]
34. E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.
Strasser A; Harris AW; Cory S
Oncogene; 1993 Jan; 8(1):1-9. PubMed ID: 8423986
[TBL] [Abstract][Full Text] [Related]
35. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
36. Several types of adherent cells elaborate a dialyzable lymphopoietic cofactor (Abelson Growth Promoter).
Muirhead M; Davis R; Schwartz RC; Waldschmidt TJ; Ackermann L; Palumbo G; Smith RG
Int J Cell Cloning; 1990 Nov; 8(6):392-408. PubMed ID: 2273295
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow B lymphocyte development in c-abl-deficient mice.
Hardin JD; Boast S; Schwartzberg PL; Lee G; Alt FW; Stall AM; Goff SP
Cell Immunol; 1995 Oct; 165(1):44-54. PubMed ID: 7671324
[TBL] [Abstract][Full Text] [Related]
38. Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice.
Durandy A; Emilie D; Peuchmaur M; Forveille M; Clement C; Wijdenes J; Fischer A
J Immunol; 1994 Jun; 152(11):5361-7. PubMed ID: 8189054
[TBL] [Abstract][Full Text] [Related]
39. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
40. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
